Alle Insider-Transaktionen auf den wichtigsten Aktienmärkten
Hält derzeit Positionen bei Fortress Biotech Inc, Biophytis SA, ImClone LLC, Biogen Inc, Verastem Inc and Fortress Biotech Inc
| 30 Tage | Letzte 90 Tage | 120 Tage | |
|---|---|---|---|
| Durchschnittliche Rendite | 0% | 8.2% | 15.1% |
| Erfolgsquote | 7% | 68% | 82% |
| Transaktionen |
2
100% Kauf
|
34
71% Kauf
|
47
69% Kauf
|
| Position | Unternehmen | Zeitraum |
|---|---|---|
| Co-Vice Chairman and Director | Fortress Biotech Inc | 31. Dezember 2015 - |
| Director | Biophytis SA | None - |
| Executive Vice President - Clinical Research, Chief Medical Officer | ImClone LLC | 1. Dezember 2007 - |
| Independent Director | Biogen Inc | 22. März 2010 - |
| Independent Director | Verastem Inc | 3. Mai 2017 - |
| Vice Chairman of the Board | Fortress Biotech Inc | 27. Januar 2014 - |
| Chairman of the Board | Navidea Biopharmaceuticals Inc | 22. September 2016 - 31. März 2018 |
| Director | Navidea Biopharmaceuticals Inc | 1. Juli 2010 - 22. September 2016 |
| Vice Chairman of the Board | Fortress Biotech Inc | 27. Januar 2014 - 31. Dezember 2015 |
| Executive Vice President, Chief Medical Officer and Head of Research and Development | Stemline Therapeutics Inc | 1. November 2011 - 27. Oktober 2015 |
| Co-Vice Chairman of the Board | Fortress Biotech Inc | 1. Oktober 2010 - 27. Januar 2014 |